Inactivation of nuclear factor κB by MIP-based drug combinations augments cell death of breast cancer cells

Background: Drug combination therapy to treat cancer is a strategic approach to increase successful treatment rate. Optimizing combination regimens is vital to increase therapeutic efficacy with minimal side effects. Materials and methods: In the present study, we evaluated the in vitro cytotoxicity...

Full description

Bibliographic Details

Main Authors:	Subramaniam, Menaga, Liew, Su Ki, In, Lionel L.A., Awang, Khalijah, Ahmed, Niyaz, Nagoor, Noor Hasima
Format:	Article
Published:	Dove Medical Press 2018
Subjects:	Q Science (General) QD Chemistry QH Natural history R Medicine
Online Access:	http://eprints.um.edu.my/20607/ https://doi.org/10.2147/DDDT.S141925
Tags:	Add Tag No Tags, Be the first to tag this record!